Leonard Bell, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 6,716 shares at $131.71 ($886K) on 2017-02-28, disclosed to the SEC on 2017-03-01.
Seasonal sale ($886k) by Director — this insider has traded ALXN in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $131.71 | 2,738 | $361K | 40.7% |
| 2 | $131.71 | 2,738 | $361K | 40.7% |
| 3 | $132.50 | 1,240 | $164K | 18.6% |
| Total | $131.86 avg | 6,716 | $886K | 100% |
| Filing → |
| ALXN | SELL | 2017-01-13 | $14K | — | Filing → |
| ALXN | SELL | 2017-01-09 | $5.5M | — | Filing → |
| ALXN | SELL | 2016-11-07 | $5.2M | — | Filing → |